
Doctors. Drugs. Unfiltered opinions. The unvarnished truth. These are things that are rarely if ever, seen together. Here you can find an informed, objective alternative to the medical party line. Join me.
| Platform | Pricing | Freemium | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 76 | Subscribers | Read | drpetergrinspoon.substack.com |
Curious about how many subscribers Grinspoon on Drugs has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Recent posts by this newsletter. Browse the email archive.
The idea for this piece came from my incredibly brilliant wife Lizzi. The ideas are mostly hers. She has been with me for the addiction journey since we first met in 2009 and has developed a unique, intuitive knowledge of these issues. Her ...
Disclaimer: the cannabis industry is not one homogenous entity. This article is concerned with the corporate behemoths, the Multi-State Operators (MSOs,) such as Curaleaf and Trulieve, that are trying to dominate the cannabis market. It is ...
Twenty years ago, when I was addicted to prescription painkillers, a pill was just a pill. If you crushed up and snorted a thirty milligram Oxycontin, the effects were predictable, even if the addiction itself was soul-crushing and life-des...
Australian band named after my father
Other publications recommended by the authors of this newsletter.
The writers behind this newsletter.
Peter Grinspoon, MD, is a primary care physician at Mass General Hospital, an Instructor in Medicine at Harvard Medical School, and a cannabis specialist. His new book, Aging Well with Cannabis is available for preorder and publishes May 5, 2026
You can find recent issues that have been published by Grinspoon on Drugs on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Grinspoon on Drugs, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Grinspoon on Drugs as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Grinspoon on Drugs using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Similar Newsletters to see other publications like Grinspoon on Drugs. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.